FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News BPC 157: The peptide with big claims and scant evidence STAT An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica Musculoskeletal and Tissue Healing with BPC 157: Weight Loss and Vitality: Medical Weight Loss BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved